The development of irreversible itk inhibitors as a potential new treatment for severe asthma

Sébastien André Campos, William Kerr, John D Harling, Angela M Deakin, Nick Barton, Dom Somers, Laiq Chaudry, Rachel Grimley, John William Barrett, Rebecca H Graves, Roberto Solari

Research output: Contribution to conferenceSpeech

Original languageEnglish
Publication statusPublished - 19 Nov 2014
EventSociety of Chemical Industry, Young Chemist In Industry 2014 - GlaxoSmithKline Medicines Research Centre, Stevenage, United Kingdom
Duration: 19 Nov 201419 Nov 2014

Conference

ConferenceSociety of Chemical Industry, Young Chemist In Industry 2014
Country/TerritoryUnited Kingdom
CityStevenage
Period19/11/1419/11/14

Keywords

  • irreversible itk inhibitors
  • asthma treatment

Cite this